BillionToOne

Founders

Oguzhan Atay
David Tsao

Location

Türkiye
United States

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.

Learn More

BillionToOne claims billion-dollar valuation with $130M funding round
Austin, Texas Attracts BillionToOne Project and Bring 1,000 Jobs
Culmination Bio and BillionToOne partner to advance cancer diagnosis
BillionToOne Closes $125M Series C Funding with Premier Global Investors
BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility